PolarityTE Investor Relations Material

Latest events

Q2 2022

PolarityTE

Q3 2022

10 Nov, 2022

Q2 2022

11 Aug, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from PolarityTE Inc

Access all reports
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. PolarityTE has developed unique capabilities for producing customized acellularized human tissues that it uses to manufacture and license a portfolio of products. Its ITR Technology Platform includes proprietary maintenance medium and home-use kits, as well as reagent kits to generate Acellular Human Osteochondral Tissue (AHOST) grafts from donor cartilage.